BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vascellari S, Palmas V, Melis M, Pisanu S, Cusano R, Uva P, Perra D, Madau V, Sarchioto M, Oppo V, Simola N, Morelli M, Santoru ML, Atzori L, Melis M, Cossu G, Manzin A. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease. mSystems 2020;5:e00561-20. [PMID: 32934117 DOI: 10.1128/mSystems.00561-20] [Cited by in Crossref: 24] [Cited by in F6Publishing: 56] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Yan Z, Liu L, Zhang R, Zhang X, Peng C, Geng Y, Zhou F, Han Y, Hou X. Characteristics of gut microbiota of term small gestational age infants within 1 week and their relationship with neurodevelopment at 6 months. Front Microbiol 2022;13:912968. [DOI: 10.3389/fmicb.2022.912968] [Reference Citation Analysis]
2 Mohr AE, Jasbi P, Vander Wyst KB, van Woerden I, Shi X, Gu H, Whisner CM, Bruening M. Association of food insecurity on gut microbiome and metabolome profiles in a diverse college-based sample. Sci Rep 2022;12:14358. [PMID: 35999348 DOI: 10.1038/s41598-022-18515-y] [Reference Citation Analysis]
3 Liu H, Yin X, Li J, Cao Y, Wang Y, Mu W, Zhuo Z, Chen L, Zhang Z, Qu X, Wang C, Zhang Z. Preoperative Intestinal Microbiome and Metabolome in Elderly Patients with Delayed Neurocognitive Recovery. Anaesth Crit Care Pain Med 2022;:101140. [PMID: 35963525 DOI: 10.1016/j.accpm.2022.101140] [Reference Citation Analysis]
4 Zeng J, Wang X, Pan F, Mao Z. The relationship between Parkinson’s disease and gastrointestinal diseases. Front Aging Neurosci 2022;14:955919. [DOI: 10.3389/fnagi.2022.955919] [Reference Citation Analysis]
5 Schemczssen-graeff Z, Pileggi M. Probiotics and live biotherapeutic products aiming at cancer mitigation and patient recover. Front Genet 2022;13:921972. [DOI: 10.3389/fgene.2022.921972] [Reference Citation Analysis]
6 Jalandra R, Dhar R, Pethusamy K, Sharma M, Karmakar S. Dysbiosis: Gut feeling. F1000Res 2022;11:911. [DOI: 10.12688/f1000research.122429.1] [Reference Citation Analysis]
7 Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C. Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease. Microorganisms 2022;10:1544. [DOI: 10.3390/microorganisms10081544] [Reference Citation Analysis]
8 Chen G, Shi F, Yin W, Guo Y, Liu A, Shuai J, Sun J. Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions. Front Microbiol 2022;13:916765. [DOI: 10.3389/fmicb.2022.916765] [Reference Citation Analysis]
9 Sun X, Xue L, Wang Z, Xie A. Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism. Front Neurosci 2022;16:878239. [PMID: 35873830 DOI: 10.3389/fnins.2022.878239] [Reference Citation Analysis]
10 Rahman Z, Dandekar MP. Implication of Paraprobiotics in Age-Associated Gut Dysbiosis and Neurodegenerative Diseases. Neuromolecular Med 2022. [PMID: 35879588 DOI: 10.1007/s12017-022-08722-1] [Reference Citation Analysis]
11 Jo S, Kang W, Hwang YS, Lee SH, Park KW, Kim MS, Lee H, Yoon HJ, Park YK, Chalita M, Lee JH, Sung H, Lee JY, Bae JW, Chung SJ. Oral and gut dysbiosis leads to functional alterations in Parkinson's disease. NPJ Parkinsons Dis 2022;8:87. [PMID: 35798742 DOI: 10.1038/s41531-022-00351-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mu J, Lin Q, Liang Y. An update on the effects of food-derived active peptides on the intestinal microecology. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2022.2094889] [Reference Citation Analysis]
13 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Palmas V, Pisanu S, Madau V, Casula E, Deledda A, Cusano R, Uva P, Loviselli A, Velluzzi F, Manzin A. Gut Microbiota Markers and Dietary Habits Associated with Extreme Longevity in Healthy Sardinian Centenarians. Nutrients 2022;14:2436. [PMID: 35745166 DOI: 10.3390/nu14122436] [Reference Citation Analysis]
15 Dai W, Liu J, Qiu Y, Teng Z, Li S, Yuan H, Huang J, Xiang H, Tang H, Wang B, Chen J, Wu H. Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence. Front Pharmacol 2022;13:893567. [PMID: 35677440 DOI: 10.3389/fphar.2022.893567] [Reference Citation Analysis]
16 Dadgostar E, Moghanlou M, Parvaresh M, Mohammadi S, Khandan M, Aschner M, Mirzaei H, Tamtaji OR. Can Berberine Serve as a New Therapy for Parkinson's Disease? Neurotox Res 2022. [PMID: 35666433 DOI: 10.1007/s12640-022-00526-2] [Reference Citation Analysis]
17 Ishimwe JA, Breier N, Saleem M, Kastner PD, Kirabo A, Shibao CA. The Gut Microbiota and Short-Chain Fatty Acids Profile in Postural Orthostatic Tachycardia Syndrome. Front Physiol 2022;13:879012. [DOI: 10.3389/fphys.2022.879012] [Reference Citation Analysis]
18 Chang Y, Yeh K, Huang J, Su K, Tsai M, Hua M, Liao S, Lai S, Chen L, Chiu C. Metabolomics analysis reveals molecular linkages for the impact of vitamin D on childhood allergic airway diseases. Pediatric Allergy Immunology 2022;33. [DOI: 10.1111/pai.13785] [Reference Citation Analysis]
19 Wang N, Yang L, Shang L, Liang Z, Wang Y, Feng M, Yu S, Li X, Gao C, Li Z, Luo J. Altered Fecal Metabolomics and Potential Biomarkers of Psoriatic Arthritis Differing From Rheumatoid Arthritis. Front Immunol 2022;13:812996. [PMID: 35296075 DOI: 10.3389/fimmu.2022.812996] [Reference Citation Analysis]
20 Voigt RM, Wang Z, Brown JM, Engen PA, Naqib A, Goetz CG, Hall DA, Metman LV, Shaikh M, Forsyth CB, Keshavarzian A. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105780] [Reference Citation Analysis]
21 Wang W, Zhu G, Wang Y, Li W, Yi S, Wang K, Fan L, Tang J, Chen R. Multi-Omics Integration in Mice With Parkinson’s Disease and the Intervention Effect of Cyanidin-3-O-Glucoside. Front Aging Neurosci 2022;14:877078. [DOI: 10.3389/fnagi.2022.877078] [Reference Citation Analysis]
22 Mitrea L, Nemeş SA, Szabo K, Teleky BE, Vodnar DC. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Front Med (Lausanne) 2022;9:813204. [PMID: 35433746 DOI: 10.3389/fmed.2022.813204] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
23 Pereira PAB, Trivedi DK, Silverman J, Duru IC, Paulin L, Auvinen P, Scheperjans F. Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson's disease. NPJ Parkinsons Dis 2022;8:39. [PMID: 35411052 DOI: 10.1038/s41531-022-00300-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ye Z, Zhang Y, Du M, Lu S, Zhao Q, Yang S. The Correlation Between Probiotics and Anxiety and Depression Levels in Cancer Patients: A Retrospective Cohort Study. Front Psychiatry 2022;13:830081. [DOI: 10.3389/fpsyt.2022.830081] [Reference Citation Analysis]
25 Guo T, Chen L. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights. Eur J Inflamm 2022;20:1721727X2210837. [DOI: 10.1177/1721727x221083763] [Reference Citation Analysis]
26 Murros KE. Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease. Cells 2022;11:978. [DOI: 10.3390/cells11060978] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Guo C, Huo YJ, Li Y, Han Y, Zhou D. Gut-brain axis: Focus on gut metabolites short-chain fatty acids. World J Clin Cases 2022; 10(6): 1754-1763 [DOI: 10.12998/wjcc.v10.i6.1754] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Shen Y, Jiang Y, Zhang S, Zou J, Gao X, Song Y, Zhang Y, Hu Y, Huang Y, Jiang Q. The Effect of Dietary Supplementation with Resveratrol on Growth Performance, Carcass and Meat Quality, Blood Lipid Levels and Ruminal Microbiota in Fattening Goats. Foods 2022;11:598. [PMID: 35206074 DOI: 10.3390/foods11040598] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Schumacher-schuh A, Bieger A, Borelli WV, Portley MK, Awad PS, Bandres-ciga S. Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases. Front Neurol 2022;12:792227. [DOI: 10.3389/fneur.2021.792227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Sharma R. Emerging Interrelationship Between the Gut Microbiome and Cellular Senescence in the Context of Aging and Disease: Perspectives and Therapeutic Opportunities. Probiotics Antimicrob Proteins 2022. [PMID: 34985682 DOI: 10.1007/s12602-021-09903-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
31 O'riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, Fülling C, Morley SJ, Clarke G, Schellekens H, Cryan JF. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Molecular and Cellular Endocrinology 2022. [DOI: 10.1016/j.mce.2022.111572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
32 Solch RJ, Aigbogun JO, Voyiadjis AG, Talkington GM, Darensbourg RM, O'connell S, Pickett KM, Perez SR, Maraganore DM. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review. Journal of the Neurological Sciences 2022. [DOI: 10.1016/j.jns.2022.120166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Junca H, Pieper DH, Medina E. The emerging potential of microbiome transplantation on human health interventions. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Wang W, Yang S, Song S, Zhang J, Jia F. Flammulina velutipes mycorrhizae dietary fiber improves lipid metabolism disorders in obese mice through activating AMPK signaling pathway mediated by gut microbiota. Food Bioscience 2021;43:101246. [DOI: 10.1016/j.fbio.2021.101246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ren Q, Wei F, Yuan C, Zhu C, Zhang Q, Quan J, Sun X, Zheng S. The effects of removing dead bacteria by propidium monoazide on the profile of salivary microbiome. BMC Oral Health 2021;21:460. [PMID: 34551743 DOI: 10.1186/s12903-021-01832-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Doroszkiewicz J, Groblewska M, Mroczko B. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System. Int J Mol Sci 2021;22:10028. [PMID: 34576191 DOI: 10.3390/ijms221810028] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Fonseca Cabral G, Schaan AP, Cavalcante GC, Sena-Dos-Santos C, de Souza TP, Souza Port's NM, Dos Santos Pinheiro JA, Ribeiro-Dos-Santos Â, Vidal AF. Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson's Disease. Int J Mol Sci 2021;22:9839. [PMID: 34576000 DOI: 10.3390/ijms22189839] [Reference Citation Analysis]
38 Scholefield M, Church SJ, Xu J, Patassini S, Hooper NM, Unwin RD, Cooper GJS. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson's Disease Dementia. Metabolites 2021;11:569. [PMID: 34564384 DOI: 10.3390/metabo11090569] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Sini P, Dang TBC, Fais M, Galioto M, Padedda BM, Lugliè A, Iaccarino C, Crosio C. Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons. Int J Mol Sci 2021;22:8726. [PMID: 34445429 DOI: 10.3390/ijms22168726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
40 Tobin D, Vige R, Calder PC. Review: The Nutritional Management of Multiple Sclerosis With Propionate. Front Immunol 2021;12:676016. [PMID: 34394076 DOI: 10.3389/fimmu.2021.676016] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
41 Vascellari S, Manzin A. Parkinson's Disease: A Prionopathy? Int J Mol Sci 2021;22:8022. [PMID: 34360787 DOI: 10.3390/ijms22158022] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Ray B, Mahalakshmi AM, Tuladhar S, Bhat A, Srinivasan A, Pellegrino C, Kannan A, Bolla SR, Chidambaram SB, Sakharkar MK. "Janus-Faced" α-Synuclein: Role in Parkinson's Disease. Front Cell Dev Biol 2021;9:673395. [PMID: 34124057 DOI: 10.3389/fcell.2021.673395] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
43 Liang J, Kou S, Chen C, Raza SHA, Wang S, Ma X, Zhang WJ, Nie C. Effects of Clostridium butyricum on growth performance, metabonomics and intestinal microbial differences of weaned piglets. BMC Microbiol 2021;21:85. [PMID: 33752593 DOI: 10.1186/s12866-021-02143-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
44 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433. [PMID: 33804226 DOI: 10.3390/biom11030433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
45 Zhang Y, Li J, Zhang X, Song D, Tian T. Advances of Mechanisms-Related Metabolomics in Parkinson's Disease. Front Neurosci 2021;15:614251. [PMID: 33613180 DOI: 10.3389/fnins.2021.614251] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
46 Vascellari S, Melis M, Palmas V, Pisanu S, Serra A, Perra D, Santoru ML, Oppo V, Cusano R, Uva P, Atzori L, Morelli M, Cossu G, Manzin A. Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes. Biomolecules 2021;11:144. [PMID: 33499229 DOI: 10.3390/biom11020144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
47 Kang Y, Kang X, Zhang H, Liu Q, Yang H, Fan W. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy. ASN Neuro 2021;13:17590914211016217. [PMID: 34053243 DOI: 10.1177/17590914211016217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
48 Gorecki AM, Bakeberg MC, Theunissen F, Kenna JE, Hoes ME, Pfaff AL, Akkari PA, Dunlop SA, Kõks S, Mastaglia FL, Anderton RS. Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease. Front Aging Neurosci 2020;12:603849. [PMID: 33328979 DOI: 10.3389/fnagi.2020.603849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
49 Nishiwaki H, Hamaguchi T, Ito M, Ishida T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder. mSystems 2020;5:e00797-20. [PMID: 33293403 DOI: 10.1128/mSystems.00797-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]